IBEX vs SUPX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IBEX exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial stability and operational efficiency. The stock is currently trading at $27.49, which is essentially at its Graham Number ($27.9) and significantly below its growth-based intrinsic value of $88.79. Despite a bearish technical trend and recent insider selling by the CEO, the combination of a low P/E (9.13), high ROE (33.65%), and robust earnings growth (45.6% YoY) presents a compelling value opportunity.
SUPX exhibits severe financial distress and extreme overvaluation, anchored by a weak Piotroski F-Score of 3/9. While the company shows impressive YoY revenue growth of 130.40%, this is completely offset by a disastrous operating margin of -201.13% and a Price-to-Sales ratio of 103.77, which is unsustainable for any software infrastructure firm. The stock has experienced a catastrophic 85.4% decline over the last six months, reflecting a total collapse in market confidence. With no earnings, no dividend, and a bearish technical trend, the company is currently a high-risk speculative asset.
Compare Another Pair
Related Comparisons
IBEX vs SUPX: Head-to-Head Comparison
This page compares IBEX Limited (IBEX) and SuperX AI Technology Limited (SUPX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.